Catheter Precision VTAK
NYSE VTAK
$0.21 0.00 (-0.66%)
At close: Aug 20, 2026 · 1:06 PM UTC

Catheter Precision (VTAK) Acquisitions (2023 - 2026)

Catheter Precision (VTAK) posted quarterly Acquisitions of $1.2 million for Q1 2026, up 3933.33% quarter-over-quarter from $30000.0 in Q4 2023.

Catheter Precision (VTAK) Acquisitions (2023 - 2026) Analysis & Trends

Catheter Precision (VTAK) has reported Acquisitions for 2 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Acquisitions changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2023 annual figure was $15000.0, changed N/A from the prior year.
  • Acquisitions climbed to $1.2 million in Q1 2026 per VTAK's latest filing, from $30000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $72.6 million in Q2 2023 and bottomed at -$72.6 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn -
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 437.00 Mn
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn -
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn -
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn -4.00 Mn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn -3.49 Mn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 16.00 Mn
10 Catheter Precision 586,420.52 -1.25 Mn 98,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.21 Mn
Dec 31, 2023 30,000.00
Sep 30, 2023 -72.56 Mn
Jun 30, 2023 72.56 Mn
Mar 31, 2023 -15,000.00